Stuart Walter Peltz, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 5,897 shares at $44.36 ($257K) on 2023-01-11, disclosed to the SEC on 2023-01-12.
Seasonal sale ($257k) by CHIEF EXECUTIVE OFFICER — this insider has traded PTCT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.93 | 571 | $25K | 9.5% |
| 2 | $42.93 | 1,228 | $53K | 20.5% |
| 3 | $42.93 | 1,228 | $53K | 20.5% |
| 4 | $44.36 | 492 | $22K | 8.5% |
| 5 | $44.36 | 1,189 | $53K | 20.5% |
| 6 | $44.36 | 1,189 |
| $53K |
| 20.5% |
| Total | $43.63 avg | 5,897 | $257K | 100% |
| Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |
| PTCT | SELL | 2022-04-15 | $4K | — | Filing → |